Date: 19 Muharram 1444   Tuesday 16 August 2022

  • Last Update: Tuesday 16 August 2022، 08:12:05.

Japan grants emergency approval for Pfizer’s oral COVID-19 pill

07:10 11 February 2022 Author :  

Japan’s Health Ministry on Thursday granted emergency approval for the use of the oral COVID-19 pill made by US drugmaker Pfizer.

The drug, Paxlovid, will be used to treat people with mild symptoms of the coronavirus.

Last December, Japanese authorities also approved American Merck & Co’s molnupiravir oral drug for the treatment of the coronavirus.

Japan is witnessing a sixth wave of COVID-19 driven by the omicron variant, with the government extending the quasi-state of emergency in 13 provinces until March.

The country has already agreed with the Japanese arm of US pharmaceutical giant Pfizer to procure enough of the drug for 2 million people within the year. Following the ministry's approval, the government will initially secure enough for 40,000 people.

Japan has reported more than 3.56 million COVID-19 cases, including 19,742 deaths, since the start of the pandemic./aa

Read 1302

Related News:


Partly Cloudy



Partly Cloudy

Humidity: 75%

Wind: 30.58 km/h

  • 04 Jan 2019

    Sunny 18°C 12°C

  • 05 Jan 2019

    Mostly Sunny 17°C 11°C

  • Most Popular
  • Most Commented